Cyberknife Precision Radiation Delivery System for Tumors of the Spine

The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spinal Cord Cancer Brain (Nervous System) Cancers Neoplasms Nervous System Diseases Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

5 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

- Intra-axial, extra-axial, or vertebral spinal lesion

Age > 5
Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion
No rapidly deteriorating symptoms of spinal cord compression
No instability of the spine
Life expectancy > 6 months Exclusion Criteria:- Patients without tumors of the spine
Patients younger than 5 years old

Treatment and study plan

Stereotactic radiosurgery

Procedure

Primary outcomes

Usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions

Time frame: completed

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Registry information

Important dates

Study start: 2002
Primary completion: 2006
Study completion: 2006
First posted: Sep 16, 2005
Registry last updated: Jul 14, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting